Akari Therapeutics

#Akari Therapeutics #Antibody drug conjugate (ADC) #Mergers and acquisitions #Peak Bio #Stem cells

Akari Therapeutics and Peak Bio announce merger

Biotechnology company Akari Therapeutics and biopharmaceutical company Peak Bio have announced a definitive agreement to merge as equals in an all-stock transaction. The combined entity will operate as Akari Therapeutics, which is expected to continue to be listed and trade on the Nasdaq Capital Market as… Read More

#Business & Investment #News